Studies related to Liver Enzymes and L-Carnitine

Acetyl-L-carnitine Reduces Depression And Improves Quality Of Life In Patients With Minimal Hepatic Encephalopathy

Effect Decrease
Values AST. Mean and SD. Placebo: before 80.4 ± 19.8, after 54.6 ± 15.6. Carnitine: before 102.1 ± 15.2, after49.6 ± 17. ALT: Placebo: before 90.2 ± 14.3, after 55.4 ± 14.1. Carnitine: before 117.4 ± 16, after 51.2 ± 18.3.
Trial Design Double blind
Trial Length n/a
Number of Subjects 67
Sex n/a
Notes for this study:
Acetyl-L-Carnitine at 4g a day (2g, twice a day) was associated with decreased depression and improved quality of life as a result of hepatic encepalopathy.

Full details on all 12 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.